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Objectives: Issues such as specimen adequacy and diagnostic yield have rarely been studied in rural
regions. This study investigated specimen adequacy and the diagnostic yield of cervical smears from
outreach screening services in remote regions in eastern Taiwan.
Materials and methods: There were 5670 smears from outreach screening services; 649 smears were
taken in mobile screening van units or in temporary walk-in clinics. The quality, compromising factors,
and positive rates of smears from mobile screening van units and temporary walk-in clinics were
compared with those obtained in physician ofﬁces.
Results: The quality of smears from physician ofﬁces was better than the quality from mobile van
screening units and temporary walk-in clinics; the satisfactory rates were 72%, 54%, and 53%, respectively
(c2 ¼ 109.9910, p < 0.0001; df ¼ 4). The most important limiting factor, absence of endocervical
component (ECC), was reported in 56%, 57%, and 73% of suboptimal smears at physician ofﬁces, mobile
van screening units, and temporary walk-in clinics, respectively (c2 ¼ 25.2780, p < 0.001; df ¼ 2). Poor
ﬁxation compromised 18%, 18%, and 14% of smears taken at physician ofﬁces, mobile van screening units,
and temporary walk-in clinics, respectively. For smears taken in physician ofﬁces, the odds ratio for
positivity of suboptimal smears with ECC was nine times the odds ratio of suboptimal smears with no
ECC.
Conclusion: The issue of quality of specimens from outreach services in rural areas needs to be
emphasized to improve the sensitivity of the test. In future studies, the difﬁculties that health workers
encounter when taking smears in outreach services and the underlying sociocultural and demographic
barriers need to be elucidated.
Copyright © 2014, Buddhist Compassion Relief Tzu Chi Foundation. Published by Elsevier Taiwan LLC. All
rights reserved.1. Introduction
In 2012, cervical cancer was the ninth most common type of
cancer in women in developed countries (age-adjusted mortality
rate, 3.3 per 100,000 women) [1]. By contrast, it was the third most
common type of cancer in developing countries (8.3 per 100,000
women). Since the introduction of cervical smear screening by
George Papanicolaou, the incidence andmortality of cervical cancer
have declined in many developed countries [2e4]. In Finland,edicine, Buddhist Tzu Chi
ualien, Taiwan. Tel.: þ886 3
eng).
elief Tzu Chi Foundation. Publishewhere organized cervical screening was introduced in the 1960s,
there was a decrease of 80% in the age-adjusted incidence and in
the mortality of cervical cancer by the beginning of the 1990s [5].
Similar trends have been noted in developed countries with orga-
nized programs. In 2010 in Taiwan, cervical cancer had the sixth
highest cancer mortality rate in females [6]. Mortality from cervical
cancer in women aged > 30 years has decreased by 62.7%: the age-
adjusted mortality rate was 22.0 per 100,000 women in 1997 and
8.2 per 100,000 women in 2011 [7]. This ﬁnding generally concurs
with ﬁndings from developed countries that have organized
screening programs in place.
Before the National Health Insurance (NHI) Program (Taipei,
Taiwan) was established in 1995, cervical screening was performed
opportunistically and haphazardly in Taiwan. A mass screening
program was provided by the Taiwan Cancer Society from 1974 tod by Elsevier Taiwan LLC. All rights reserved.
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throughout the country. However, only 5.3% of eligible women
were covered [8]. It was not until 1996 that a centrally organized
cervical screening program was initiated. The screening program
was funded by the NHI Program. It covers nearly 98% of the pop-
ulation. This cervical screening program was a health target pro-
gram. It was listed as the top priority target of the 5-year National
Cancer Prevention Project. Annual cervical screening is offered free
to all women older than 30 years; in addition, human papilloma
virus (HPV) self-testing is offered to people older than 36 years and
in disabled women older than 30 years [7].
Outreach screening services are commonly used worldwide to
reach rural residents to improve access to cancer preventive ser-
vices and increase screening uptake [7]. To reduce health service
disparities in rural regions, the Health Promotion Administration in
Taiwan has been sponsoring and promoting outreach services in
remote regions to provide cervical smears for marginalized and
underserved women. In routine medical practice, Pap smears are
conventionally taken by physicians in hospitals or private clinics. To
breach sex and sociocultural barriers in rural areas, it is a common
practice to recruit female aboriginal health center nurses to take
Pap smears. To further boost uptake, outreach teams working in
alliance with aboriginal health services and bilingual health
workers send out postcards to notify residents in villages about the
dates, times, and locations of outreach services that smears will be
taken. They also organize group bookings of screening services in
local activity centers during special gatherings of local villagers or
in local elderly unions. Mobile van screening units and temporary
walk-in clinics have been utilized in rural areas for outreach pur-
poses [7]. These temporary walk-in clinics are established in local
activity centers sports centers, or local school gymnasiums and
school auditoriums. Temporary walk-in clinics use ordinary tables
instead of bulky gynecologic examination tables and use simple
curtains for privacy. On mass screening days, the screening unit
staff traveled to the designated area in the rural communities in the
early morning to reach women before they went to work. These
outreach screening services rotate throughout different villages
annually to facilitate cervical sampling in remote regions. This
project targeted women older than 30 years, although all women
who were sexually active were welcome to register for the service.
When abnormalities are detected, patients are tracked by public
health nurses and are referred to the appropriate regional treat-
ment centers.
To the best of our knowledge, however, issues such as specimen
adequacy and diagnostic yield have rarely been investigated in
remote regions. In this study, we evaluated the specimen adequacy
and diagnostic yield of smears that were taken in outreach
screening programs in rural eastern Taiwan, and explored the most
likely causes that compromise specimen quality.2. Materials and methods
The data used for analysis was based on the screening results
reported by a pathology laboratory at a university-afﬁliated hos-
pital in eastern Taiwan between January 2006 and March 2011. This
laboratory handles approximately one-third of all smear readings
in eastern Taiwan. The catchment area of the source laboratory
included the area stretching along the Hua-Tung Rift Valley, which
is approximately 8044 square kilometers, and covers approxi-
mately 22.5% of the surface area of Taiwan [9e11]. It is sparsely
populated with inhabitants accounting for only 2.38% of the total
population of Taiwan [10e12]. The geography features mountains,
hills, and the valley where aboriginals account for approximately
31% of the inhabitants [9,12e14]. Outreach screening services took5670 smears; of these, 649 smears were frommobile screening van
units or from temporary walk-in clinics.
The specimen adequacy was rated as “satisfactory”, “subopti-
mal”, or “unsatisfactory”, based on the consensus reached by the
National Health Research Institutes (Taipei, Taiwan) and Taiwan
Cooperative Oncology Group (Taipei, Taiwan). Reporting was based
on a modiﬁcation of the Bethesda System [15,16]. For each subop-
timal smear, the cytopathologist was allowed to list two factors that
compromised the smear quality such as poor ﬁxation, too few cells,
thick or bloody consistency, lack of endocervical component (ECC),
inﬂammation, foreign bodies, and lysis. The variables we collected
included specimen adequacy, descriptive diagnosis, the clinic, the
type of professional taking the smear, and limiting factors that
compromised specimen quality. Eighteen different interpretation
results are listed in the descriptive diagnosis in the cancer registry
[17]. In this study, no smears were diagnosed as “adenocarcinoma
in situ” or “other malignant neoplasms.” For data visualization
purposes, the remaining 16 cytopathology descriptive diagnosis
results were grouped into four major categories: (1) “negative”; (2)
“atypical”; (3) “atypical favoring dysplasia”; and (4) “dysplasia or
malignancy” (Table 1). The quality, compromising factors, and
positive rates of smears from remote outreach services were
compared with smears from physician ofﬁces using the Chi-square
test. A p value < 0.01 was regarded as signiﬁcant. Data analysis was
performed using the statistical package STATA version 11 software
(StataCorp, College Station, TX, USA).
3. Results
Table 1 shows the cytological interpretation and specimen
quality of the smears in this study. The positive rate of smears in
remote regions was 2.98%, which included all categories, except the
“negative” category (Table 1; n ¼ 169). The satisfactory rate of the
smears overall was 70%, and the suboptimal rate was 26%. The
positive rates of the satisfactory smears and suboptimal smears
were 3.31% and 2.55% respectively.
Table 2 shows the distribution of the sampling sites and the
specimen adequacy. Elevenpercent of smearswere frommobile van
screening units or temporary walk-in clinics. The quality of smears
from physician ofﬁces was better than the quality from mobile van
screening units and temporarywalk-in clinics. The satisfactory rates
were 72% (physician ofﬁces), 54% (mobile van screening units), and
53% (temporary walk-in clinics) (c2 ¼ 109.9910, p < 0.001; df ¼ 4).
Table 3 lists the major limiting factors for suboptimal smears.
The most important limiting factor was absence of ECC. Suboptimal
smears from 56% of physician ofﬁces, 57% of mobile van screening
units, and 73% of temporary walk-in clinics lacked ECC
(c2 ¼ 25.2780, p < 0.001; df ¼ 2). Furthermore, the suboptimal
smears were compromised by poor ﬁxation in physician ofﬁces
(18% of smears), mobile van screening units (18% of smears), and
temporary walk-in clinics (14% of smears), although the difference
was not signiﬁcant (p ¼ 0.324).
The positive rates of smears from physician ofﬁces, mobile van
screening units, and temporary walk-in clinics were 3.26%, 4.05%,
and 1.51%, respectively (Table 4). The odds ratio of positivity for
suboptimal smears containing ECC from physician ofﬁces was 9.06
times that of suboptimal smears containing no ECC (p < 0.001). The
odds ratio of positivity for suboptimal smears containing ECC from
temporary walk-in clinics was 2.74 times that of suboptimal smears
containing no ECC (p ¼ 0.29).
4. Discussion
Four characteristics of failed cervical screening programs have
been identiﬁed: (1) failure to reach at-risk women, (2) inadequate
Table 3
The limiting factors of suboptimal smears at the different sampling sites.





Descriptive diagnosis and specimen adequacy among smears taken in remote eastern Taiwan.
Descriptive diagnosis No. (%) Specimen adequacy
Suboptimal, n (%) Satisfactory, n (%) Unsatisfactory, n (%)
Negative (n ¼ 5281)
Within normal limits 3599 (63) 984 (17) 2615 (46) 0
Reactive changes 1649 (29) 462 (8) 1187 (21) 0
Atrophy with inﬂammation 33 (1) 4 (0) 29 (1) 0
Atypical (n ¼ 103)
Atypical squamous cells 56 (1) 14 (0) 42 (1) 0
Atypical glandular cells 8 (0) 1 (0) 7 (0) 0
Mild dysplasia with KC 15 (0) 3 (0) 12 (0) 0
Mild dysplasia without KC 24 (0) 6 (0) 18 (0) 0
Atypical favor dysplasia (n ¼ 25)
AGC, favor neoplasia 3 (0) 0 (0) 3 (0) 0
ASC, cannot exclude HSIL 14 (0) 3 (0) 11 (0) 0
Dysplasia, cannot exclude HSIL 8 (0) 0 (0) 8 (0) 0
Dysplasia or malignancy (n ¼ 41)
Moderate dysplasia 8 (0) 2 (0) 6 (0) 0
Severe dysplasia 17 (0) 4 (0) 13 (0) 0
Carcinoma in situ 2 (0) 0 (0) 2 (0) 0
Squamous cell carcinoma 12 (0) 4 (0) 8 (0) 0
Adenocarcinoma 2 (0) 1 (0) 1 (0) 0
Others (n ¼ 220) 220 (4) 0 (0) 0 (0) 220 (4)
Total 5670 (100) 1488 (26) 3962 (70) 220 (4)
The data are presented as n or n (%).
AGC ¼ atypical glandular cells; ASC ¼ atypical squamous cells; HSIL ¼ high-grade squamous intraepithelial lesion; KC ¼ koilocytosis.
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years), and (4) false-negative smear results [18]. Since the 1970s in
Latin America, there have been efforts to organize cervical cytology
screening programs nationally and regionally. However, there have
been no notable changes in the cervical cancer incidence and
mortality [19]. The health system infrastructure, human power, and
effective case tracking are lacking, which could be attributed to
program failure.
In Taiwan, the nearly universal coverage by the NHI system has
greatly facilitated the buildup of the cancer registry and case
tracking system, and women do not have to pay for screening
services. The currently used cervical screening report system was
adopted and revised from the Bethesda System [20,21]. In the
Bethesda System, the evaluation of specimen adequacy provides
feedback to clinicians on the sampling technique and gives a rough
indication of how reliable the sample may be in detecting an ab-
normality. The percentage of suboptimal smears has been
decreasing. One survey of American pathologist interlaboratory
comparison programs in cervicovaginal cytology reported a satis-
factory rate of 90% and a suboptimal rate of 9%.
In 2001, the suboptimal category for specimen adequacy was
eliminated from the Bethesda System. In Taiwan, the suboptimal
category has remained in use. In this study, the satisfactory rate of
smears taken in remote regions was 70%, which was lower than the
rate of the university lab as a whole (79%) and the estimated na-
tional average (74%) [7]. In this study, mobile van screening units
and temporary walk-in clinics collected 11% of the smears. TheTable 2
Smear quality at the different sampling sites.
Sampling sites Specimen adequacy (%) Total
Satisfactory * Suboptimal Unsatisfactory
Physician ofﬁce 3617 (72) 1228 (24) 176 (4) 5021
Mobile van screening unit 46 (54) 28 (33) 11 (13) 85
Temporary walk-in clinic 299 (53) 232 (41) 33 (6) 564
The data are presented as n or n (%).
* The percentage in parentheses in this column has been analyzed using the Chi-
square test; c2 ¼ 109.9910; p < 0.001.quality of smears from physician ofﬁces was better than the quality
frommobile van screening units and temporary walk-in clinics. The
quality of smears fromwalk-in clinic seemed to be theworst among
the three locations, and nearly three-fourths of the smears lacked
ECC, which could severely compromise sensitivity (Table 4).
Studies show that specimen quality inﬂuences smear interpre-
tation and consequently the accuracy of diagnosis [22,23]. This
study and other studies showed that the positive rate decreases if
there is no ECC [24e26]. There has been little effort in researching
the quality of smears from outreach services and remote regions.
Thus, it is of utmost importance to improve specimen quality, to
target especially remote health workers who are responsible for
collecting smears, and to increase coverage in remote regions. The
importance of correct technique cannot be overstated because the
efﬁcacy of the program could be eroded and compromised by
suboptimal quality smears. According to this study, 37% of Pap
smears in rural villages are collected by public health nurses, and
86% of smears taken in mobile screening vans and rural walk-in
clinics are collected by nurses. Public health nurses who collect
smears, especially nurses whowork in remote regions, need further
support such as training in sampling techniques [27]. TheTotal 1228 (100) 28 (100) 232 (100)
Limiting factors
No ECC * 682 (56) 16 (57) 170 (73)
Poor ﬁxation 225 (18) 5 (18) 33 (14)
Few cells 179 (15) 6 (21) 16 (7)
Thick or bloody 132 (11) 3 (11) 21 (9)
Inﬂammation 82 (7) 0 16 (7)
Foreign body 10 (1) 0 0
Lysis 5 (0) 0 2 (1)
The data are presented as n or n (%).
* The percentage in parentheses in this row has been analyzed using the Chi-square
test; c2 ¼ 25.2780; p < 0.001.
ECC ¼ endocervical component.
Table 4
The positive rate of smears at the different sampling sites.
All smears With ECC Without ECC OR p
Total Pos. % Total Pos. % Total Pos. %
Physician ofﬁce 4845 158 3.3 546 29 5.3 68 4 0.6 9.06 < 0.001
Mobile van screening unit 74 3 4.1 12 1 8.3 16 0 d d 0.429
Temporary walk-in clinic 531 8 1.5 62 2 3.2 170 2 1.2 2.74 0.29
ECC ¼ endocervical component; OR ¼ odds ratio.
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services also need further investigation.
High coverage is an important prerequisite of a successful
organized screening program. The deﬁnition of coverage varies:
some reports base the deﬁnition on the percentage of target
women who have had Pap tests in their lifetime, whereas other
reports base their deﬁnition on women who have had Pap smears
in the past 3 years or 5 years [5,7,28e30]. The reliability of esti-
mates of coverage relies heavily on a good registry system because
estimates based on interviews or questionnaires are subject to
human recall. The screening interval is 5 years in Finland, which
launched the earliest organized screening program in Europe; 87%
of women aged 25e69 years have had at least one test during the
past 5 years [29]. One study reports that 60e80% of women in
Germany (depending on age group) and 57% of women in France
have had at least one test during the past 3 years [5]. In the United
States, Pap test coverage largely depends on whether the client has
insurance, and therefore low-income women are likely to be
underscreened [31]. In Taiwan, the coverage among women older
than 30 years who have had at least one smear during the past 3
years has risen steadily from 35.0% in 1997 to 55.5% in 2012 [7]. In
2012, coverage among women 30e69 years old in eastern Taiwan
reached 65.9%. Despite efforts to improve the outreach screening
program in rural eastern Taiwan, this study estimated that only
34.10% of participants in remote and rural regions had received a
Pap test in the past 5 years.
The issue of targeting rural and remote areas has received
attention worldwide. Outreach services are commonly used to
reach target populations by combining different strategies to boost
uptake such as media campaigns; group bookings; networking
with indigenous health workers and health services; increasing
grant funding; and using interpreter services, reminder letters, and
mobile screening vans [32,33]. A study conducted in the Mae Sot
District in northern Thailand, reports that using mobile units could
improve coverage to up to 70.1% of the population. The Mae Sot
District is a relatively closed and self-sufﬁcient society (i.e., people
live and work in their farming communities), which may explain
why the coverage was lower in eastern rural Taiwan. The de-
mographic changes in rural eastern Taiwan may be more drastic in
this region (e.g., people tend to move away for part-time jobs in the
forestry or highland farms).
One concern is that the chance of detecting high-grade lesions is
much higher in rural regions than the national average [28]. The
positive rate in remote regions in this study was 2.98%, which is
higher than the national average of 1.27% [7]. Women in rural or
remote regions should be especially targeted as high-risk groups as
far as their screening behaviors are concerned. The underlying
causes that hinder receiving preventive services should be further
investigated. TheWorld Health Organization (Geneva, Switzerland)
has proposed using a highly sensitive test (e.g., combining cytology
and HPV test) for high-risk women at least once or twice in their
lifetime with an emphasis on high coverage (i.e., > 80%) of the
targeted population, which seems to be a feasible and practical
solution [19].5. Conclusion
The issue of specimen quality from outreach services needs to
be emphasized to improve the sensitivity of the test. The difﬁculties
that health workers encounter during smear taking in outreach
services need further investigation. Screening uptake needs further
improvement and the underlying sociocultural or demographic
barriers should be elucidated in future studies.References
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